Open Access

Expression and correlation of CD44 and GP73 in cerebroma tissues

  • Authors:
    • Yuan Yuan
    • Lin Shi
    • Shijun Wang
  • View Affiliations

  • Published online on: January 29, 2018     https://doi.org/10.3892/ol.2018.7904
  • Pages: 4958-4962
  • Copyright: © Yuan et al. This is an open access article distributed under the terms of Creative Commons Attribution License.

Metrics: HTML 0 views | PDF 0 views     Cited By (CrossRef): 0 citations

Abstract

Cerebroma, a nervous system tumor located in the cranial cavity, seriously affects health and may even become life-threatening. The aim of the study was to investigate and discuss the expression levels of cluster of differentiation 44 (CD44) and Golgi protein 73 (GP73) in different types of cerebroma tissues and to study the correlations of CD44 and GP73. Reverse transcription‑polymerase chain reaction (RT-PCR) was used to detect the mRNA expression levels of CD44 and GP73 in four kinds of cerebroma. The immunohistochemical streptavidin-biotin complex (SABC) method was applied to measure the expression levels of CD44 and GP73 in different types of cerebroma. Subsequently, immunofluorescence and western blot analysis were performed to detect the expression levels of CD44 and GP73 in four kinds of cerebroma tissues. Statistical Product and Service Solutions (SPSS) 17.0 software was used to analyze the differences in CD44 and GP73 expression levels of the four kinds of cerebroma tissues and normal brain tissues. Transcription of CD44 and GP73 mRNAs was detected in the four kinds of cerebroma tissues, and CD44 and GP73 proteins were expressed. The immunohisto­chemical results revealed that the expression levels of CD44 and GP73 in the four kinds of cerebroma were significantly increased compared with those in normal tissues. The immuno­fluorescence results indicated that both CD44 and GP73 were expressed in four kinds of cerebroma, and the expression of CD44 was higher than that of GP73. The results of analysis of variance showed that the differences in CD44 and GP73 expression levels in the four kinds of cerebroma tissues and normal brain tissues were statistically significant (P<0.01). The results show that the expression levels of CD44 and GP73 are obviously upregulated in four kinds of cerebroma tissues, suggesting that CD44 and GP73 have great value for cerebroma research and can provide a new direction for clinical study as well as the diagnosis and treatment of cerebroma.

References

1 

Singh SK, Clarke ID, Terasaki M, Bonn VE, Hawkins C, Squire J and Dirks PB: Identification of a cancer stem cell in human brain tumors. Cancer Res. 63:5821–5828. 2003.PubMed/NCBI

2 

Galli R, Binda E, Orfanelli U, Cipelletti B, Gritti A, De Vitis S, Fiocco R, Foroni C, Dimeco F and Vescovi A: Isolation and characterization of tumorigenic, stem-like neural precursors from human glioblastoma. Cancer Res. 64:7011–7021. 2004. View Article : Google Scholar : PubMed/NCBI

3 

Singh SK, Hawkins C, Clarke ID, Squire JA, Bayani J, Hide T, Henkelman RM, Cusimano MD and Dirks PB: Identification of human brain tumour initiating cells. Nature. 432:396–401. 2004. View Article : Google Scholar : PubMed/NCBI

4 

Orian-Rousseau V and Ponta H: Perspectives of CD44 targeting therapies. Arch Toxicol. 89:3–14. 2015. View Article : Google Scholar : PubMed/NCBI

5 

Goodison S, Urquidi V and Tarin D: CD44 cell adhesion molecules. Mol Pathol. 52:189–196. 1999. View Article : Google Scholar : PubMed/NCBI

6 

Bachert C, Fimmel C and Linstedt AD: Endosomal trafficking and proprotein convertase cleavage of cis Golgi protein GP73 produces marker for hepatocellular carcinoma. Traffic. 8:1415–1423. 2007. View Article : Google Scholar : PubMed/NCBI

7 

Clement V, Sanchez P, de Tribolet N, Radovanovic I and Ruiz i Altaba A: HEDGEHOG-GLI1 signaling regulates human glioma growth, cancer stem cell self-renewal, and tumorigenicity. Curr Biol. 17:165–172. 2007. View Article : Google Scholar : PubMed/NCBI

8 

Gladson CL: The extracellular matrix of gliomas: Modulation of cell function. J Neuropathol Exp Neurol. 58:1029–1040. 1999. View Article : Google Scholar : PubMed/NCBI

9 

Diamandis P, Wildenhain J, Clarke ID, Sacher AG, Graham J, Bellows DS, Ling EK, Ward RJ, Jamieson LG, Tyers M, et al: Chemical genetics reveals a complex functional ground state of neural stem cells. Nat Chem Biol. 3:268–273. 2007. View Article : Google Scholar : PubMed/NCBI

10 

Sonoda Y, Ozawa T, Aldape KD, Deen DF, Berger MS and Pieper RO: Akt pathway activation converts anaplastic astrocytoma to glioblastoma multiforme in a human astrocyte model of glioma. Cancer Res. 61:6674–6678. 2001.PubMed/NCBI

11 

Lagadec C, Vlashi E, Della Donna L, Meng Y, Dekmezian C, Kim K and Pajonk F: Survival and self-renewing capacity of breast cancer initiating cells during fractionated radiation treatment. Breast Cancer Res. 12:R132010. View Article : Google Scholar : PubMed/NCBI

12 

Marhaba R and Zöller M: CD44 in cancer progression: Adhesion, migration and growth regulation. J Mol Histol. 35:211–231. 2004. View Article : Google Scholar : PubMed/NCBI

13 

Xu Y, Stamenkovic I and Yu Q: CD44 attenuates activation of the hippo signaling pathway and is a prime therapeutic target for glioblastoma. Cancer Res. 70:2455–2464. 2010. View Article : Google Scholar : PubMed/NCBI

14 

Anido J, Sáez-Borderías A, Gonzàlez-Juncà A, Rodón L, Folch G, Carmona MA, Prieto-Sánchez RM, Barba I, Martínez-Sáez E, Prudkin L, et al: TGF-β receptor inhibitors target the CD44(high)/Id1(high) glioma-initiating cell population in human glioblastoma. Cancer Cell. 18:655–668. 2010. View Article : Google Scholar : PubMed/NCBI

15 

Naor D, Sionov RV and Ish-Shalom D: CD44: Structure, function, and association with the malignant process. Adv Cancer Res. 71:241–319. 1997. View Article : Google Scholar : PubMed/NCBI

16 

Iczkowski KA, Bai S and Pantazis CG: Prostate cancer overexpresses CD44 variants 7–9 at the messenger RNA and protein level. Anticancer Res. 23:3129–3140. 2003.PubMed/NCBI

17 

Georgolios A, Batistatou A, Charalabopoulos A, Manolopoulos L and Charalabopoulos K: The role of CD44 adhesion molecule in oral cavity cancer. Exp Oncol. 28:94–98. 2006.PubMed/NCBI

18 

Kladney RD, Cui X, Bulla GA, Brunt EM and Fimmel CJ: Expression of GP73, a resident Golgi membrane protein, in viral and nonviral liver disease. Hepatology. 35:1431–1440. 2002. View Article : Google Scholar : PubMed/NCBI

19 

Kladney RD, Tollefson AE, Wold WS and Fimmel CJ: Upregulation of the Golgi protein GP73 by adenovirus infection requires the E1A CtBP interaction domain. Virology. 301:236–246. 2002. View Article : Google Scholar : PubMed/NCBI

20 

Hu JS, Wu DW, Liang S and Miao XY: GP73, a resident Golgi glycoprotein, is sensibility and specificity for hepatocellular carcinoma of diagnosis in a hepatitis B-endemic Asian population. Med Oncol. 27:339–345. 2010. View Article : Google Scholar : PubMed/NCBI

21 

Sun Y, Yang H, Mao Y, Xu H, Zhang J, Li G, Lu X, Sang X, Zhao H, Zhong S, et al: Increased Golgi protein 73 expression in hepatocellular carcinoma tissue correlates with tumor aggression but not survival. J Gastroenterol Hepatol. 26:1207–1212. 2011. View Article : Google Scholar : PubMed/NCBI

Related Articles

Journal Cover

April 2018
Volume 15 Issue 4

Print ISSN: 1792-1074
Online ISSN:1792-1082

Sign up for eToc alerts

Recommend to Library

Copy and paste a formatted citation
APA
Yuan, Y., Shi, L., & Wang, S. (2018). Expression and correlation of CD44 and GP73 in cerebroma tissues. Oncology Letters, 15, 4958-4962. https://doi.org/10.3892/ol.2018.7904
MLA
Yuan, Y., Shi, L., Wang, S."Expression and correlation of CD44 and GP73 in cerebroma tissues". Oncology Letters 15.4 (2018): 4958-4962.
Chicago
Yuan, Y., Shi, L., Wang, S."Expression and correlation of CD44 and GP73 in cerebroma tissues". Oncology Letters 15, no. 4 (2018): 4958-4962. https://doi.org/10.3892/ol.2018.7904